Diversified Trust’s Xeris Biopharma Holdings XERS Stock Holding History

Diversified Trust’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Hold	32,062	–	–	﹤0.01%	977
2026 Q1	$186K	Hold	32,062	–	–	﹤0.01%	983
2025 Q4	$252K	Hold	32,062	–	–	﹤0.01%	885
2025 Q3	$261K	Sell	32,062 -138,173	-81%	-$918K	0.01%	848
2025 Q2	$795K	Sell	170,235 -5,504	-3%	-$25.2K	0.02%	444
2025 Q1	$965K	Hold	175,739	–	–	0.02%	371
2024 Q4	$596K	Hold	175,739	–	–	0.01%	540
2024 Q3	$501K	Hold	175,739	–	–	0.01%	584
2024 Q2	$395K	Sell	175,739 -2	-0%	-$4	0.01%	605
2024 Q1	$388K	Buy	175,741 +20,091	+13%	+$52K	0.01%	580
2023 Q4	$366K	Sell	155,650 -19,757	-11%	-$36.5K	0.01%	593
2023 Q3	$326K	Hold	175,407	–	–	0.01%	590
2023 Q2	$460K	Buy	175,407 +19,757	+13%	+$50.3K	0.02%	492
2023 Q1	$254K	Hold	155,650	–	–	0.01%	691
2022 Q4	$207K	Hold	155,650	–	–	0.01%	723
2022 Q3	$243K	Hold	155,650	–	–	0.01%	621
2022 Q2	$240K	Hold	155,650	–	–	0.01%	632
2022 Q1	$398K	Hold	155,650	–	–	0.01%	522
2021 Q4	$456K	Buy	+155,650	New	+$336K	0.02%	488

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Diversified Trust's XERS Position: Q2 2026 in Review

Diversified Trust held its Xeris Biopharma Holdings (XERS) position steady in Q2 2026 at 32,062 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #977.

Diversified Trust first reported a position in XERS in Q4 2021 and has held it in 19 quarters since. The position peaked at $965K in Q1 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

Diversified Trust held 32,062 shares of Xeris Biopharma Holdings worth $254K as of Q2 2026.
Diversified Trust left its Xeris Biopharma Holdings share count unchanged in Q2 2026.
Xeris Biopharma Holdings made up ﹤0.01% of Diversified Trust's portfolio in Q2 2026, its #977 holding.
Diversified Trust first reported a position in Xeris Biopharma Holdings in Q4 2021 and has held it in 19 quarters since.
Diversified Trust's Xeris Biopharma Holdings position peaked at $965K in Q1 2025.
241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.